dapivirine
Sponsors
International Partnership for Microbicides, Inc.
Conditions
Acquired Immunodeficiency SyndromeHIVHIV InfectionsHIV-1-infectionHealthyHuman Immunodeficiency VirusTopical Penile Exposures
Phase 1
An Expanded Safety Study of Dapivirine Gel 4759 in Africa
CompletedNCT00917891
Start: 2009-11-30End: 2011-09-30Updated: 2011-09-12
An Expanded Safety Study of Dapivirine Gel 4789 in Africa
CompletedNCT00917904
Start: 2009-07-31End: 2010-09-30Updated: 2011-12-14
A Safety Study of Dapivirine Vaginal Ring in Africa
CompletedNCT01071174
Start: 2010-04-30End: 2011-07-31Updated: 2011-08-02
A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
CompletedNCT01144676
Start: 2010-04-30End: 2010-09-30Updated: 2010-10-06
Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures
CompletedNCT01277640
Start: 2011-03-31End: 2011-07-31Updated: 2017-09-08
DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate
CompletedNCT01731574
Start: 2012-12-31End: 2013-10-31Updated: 2017-09-08
Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women
CompletedNCT02808949
Start: 2015-02-28End: 2018-03-03Target: 16Updated: 2018-03-13
Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008
CompletedNCT05416021
Start: 2022-08-01End: 2024-07-02Updated: 2024-07-03